EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
21,684,000
Total 13F shares
8,781,775
Share change
+168,738
Total reported value
$119,557,457
Price per share
$13.60
Number of holders
53
Value change
+$1,312,484
Number of buys
24
Number of sells
25

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q3 2021

As of 30 Sep 2021, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,781,775 shares. The largest 10 holders included COWEN AND COMPANY, LLC, WASATCH ADVISORS INC, RTW INVESTMENTS, LP, BlackRock Inc., SILVERCREST ASSET MANAGEMENT GROUP LLC, VANGUARD GROUP INC, MORGAN STANLEY, PLATINUM INVESTMENT MANAGEMENT LTD, Stonepine Capital Management, LLC, and Samjo Capital LLC. This page lists 53 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.